Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Inovio Pharma upgraded to Buy at Maxim Group; tgt $10 (6.87)Maxim Group upgrades INO to Buy from Hold and sets target price at $10 with a combination of moving closer to the pivotal study in cervical dysplasia and multiple earlier stage programs moving forward with more significant data points coming throughout 2017.</td> </tr></table>"